StemBioSys
PrivateLast Round
Series C
Extension
Jun 5, 2024
Est. Valuation
$52.95M
Total Funding Raised
$20.8M
Company Overview
StemBioSys is a biotechnology company that develops cell-matrix technologies designed for the enhanced isolation, growth, and delivery of stem cells for research, diagnostic, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemBioSys Comparables
Compare StemBioSys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLamina AB | 83% | |
| Xylyx Bio | 79% | |
| Bio-Techne Corporation | 77% |
StemBioSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 5, 2024 | ||||
| Series C | Aug 1, 2021 | ||||
| Grant | Apr 30, 2019 | ||||
| Grant | Apr 30, 2019 | ||||
| Series B | May 24, 2018 | ||||
Series A | Apr 14, 2015 |
StemBioSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VelocityTX | Pre Seed |
| National Institute on Aging | Grant |
| National Institute of Environmental Health Sciences | Grant |
| Targeted Technology | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2025
Monthly visitors grew 108% MoM, reaching 2.5K.
- Nov 24, 2024
Monthly visitors grew 93% MoM, reaching 2.7K.
StemBioSys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about StemBioSys's valuation, stock price, and market status.
Is StemBioSys a public or private company?
StemBioSys is a private company.
What is the current stock price of StemBioSys?
StemBioSys is a private company with no public stock price. No recent secondary market data is available.
How much is StemBioSys worth (valuation)?
Valuation information for StemBioSys is not publicly available.
Can I buy StemBioSys stock?
StemBioSys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was StemBioSys's last funding round?
Funding round information for StemBioSys is not publicly available.
Who are the main investors in StemBioSys?
Investor information for StemBioSys is not publicly disclosed.
Will StemBioSys IPO soon?
No public IPO plans have been announced for StemBioSys.
How can I track StemBioSys secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StemBioSys's secondary market activity and sign up for updates.